CD109 Is a Novel Marker for Squamous Cell/Adenosquamous Carcinomas of the Gallbladder

Diagnostic Pathology - United Kingdom
doi 10.1186/s13000-015-0375-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Squamous Cell and Adenosquamous Carcinomas of the Gallbladder: Clinicopathological Analysis of 34 Cases Identified in 606 Carcinomas

Modern Pathology
Forensic MedicinePathology
2011English

Prothymosin-Α and Parathymosin Expression Predicts Poor Prognosis in Squamous and Adenosquamous Carcinomas of the Gallbladder

Oncology Letters
Cancer ResearchOncology
2018English

Cytokeratin 14 as a Marker of Squamous Differentiation in Transitional Cell Carcinomas.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1997English

Wdr66 Is a Novel Marker for Risk Stratification and Involved in Epithelial-Mesenchymal Transition of Esophageal Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Non-Squamous Cell Carcinomas of the Larynx

Madridge Journal of Otorhinolaryngology
2018English

USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2012English

Aldehyde Dehydrogenase Activity Is a Cancer Stem Cell Marker of Tongue Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2012English

The Microbiome of Oral Squamous Cell Carcinomas: A Functional Perspective

Current Oral Health Reports
2019English

Two Cases of Squamous Cell Carcinoma of the Gallbladder.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy